Clinical profiles of 28 patients with LEC of the salivary gland
| Characteristics | No. of Patients/Values |
|---|---|
| Sex | |
| Female | 11 (39.3%) |
| Male | 17 (60.7%) |
| Age (mean) (yr) | 12∼60 (39.3) |
| <20 | 4 (14.3%) |
| ≥20 ∼ <30 | 4 (14.3%) |
| ≥30 ∼ <40 | 6 (21.4%) |
| ≥40 ∼ <50 | 4 (14.3%) |
| ≥50 ∼ <60 | 8 (28.6%) |
| ≥60 | 2 (7.1%) |
| Symptom duration (mean) (mo) | 0.∼120 (25) |
| <24 | 16 (57.1%) |
| ≥24 | 12 (42.9%) |
| Epstein-Barr virus | |
| Positive | 27 (96.4%) |
| Negative | 1 (3.6%) |
| Clinical staging | |
| I | 1 (3.6%) |
| II | 7 (25.0%) |
| III | 8 (28.5%) |
| IV | 12 (42.9%) |
| Treatment | |
| Surgery | 7 (25%) |
| Surgery and radiotherapy | 18 (64.2%) |
| Surgery, radiotherapy, and chemotherapy | 2 (7.2%) |
| Radiotherapy and chemotherapy | 1 (3.6%) |
| Local recurrence | 3 (10.7%) |
| Distant metastasis | 4 (14.3%) |